Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients-Reference-Cited by-同舟云学术

Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients

Published:2003-11-27 Issue:10 Volume:76 Page:1444-1447
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Akalin Enver,Ames Scott,Sehgal Vinita,Fotino Marilena,Daly Lisa,Murphy Barbara,Bromberg Jonathan S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference13 articles.

1. B-cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients;Mahoney;Hum Immunol,2002

2. Crossmatch tests: An analysis of UNOS data from 1991–2000;Cho;Clin Transpl,2001

3. Flow cytometry crossmatching (FCXM) in the UNOS Kidney Transplant Registry;Cook;Clin Transpl,1998

4. Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation;El Fettouh;Urology,2000

5. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch;Karpinski;J Am Soc Nephrol,2001

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Strategies in Immune Modulation and Desensitization Protocols;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

2. The interplay of protein engineering and glycoengineering to fine‐tune antibody glycosylation and its impact on effector functions;Biotechnology and Bioengineering;2021-10-20

3. Positive Crossmatch Kidney Transplantation: State of the Art and Future Perspectives;Current Pharmaceutical Design;2020-08-31

4. Renal Transplantation Across HLA and ABO Barriers;Kidney Transplantation, Bioengineering and Regeneration;2017

5. The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation;Kidney International;2016-01